Isoprenaline Chlorhydrate Tillomed (Isoprenaline Hydrochloride)

Isoprenaline activates beta‑1 receptors in the heart, increasing heart rate and contractility, and beta‑2 receptors in the lungs, causing bronchodilation. Both actions are mediated through a rise in intracellular cyclic AMP.

The dose of Isoprenaline is determined by the prescribing clinician based on the patient’s condition, response, and clinical monitoring. Dosage regimens are individualized and should follow local prescribing guidelines.

Safety data for Isoprenaline in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by the treating physician.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Isoprenaline is a non‑selective beta‑agonist, offering both heart‑rate acceleration and bronchodilation, unlike selective agents such as dopamine or dobutamine which primarily target cardiac output. Its broader receptor activity can be advantageous in combined cardiac‑respiratory emergencies but may also increase the risk of side effects.

Store at room temperature: keep the product in its original packaging, protect it from moisture and direct light, and avoid freezing. Ensure the container is tightly sealed until use.

The medication is given intravenously under strict medical supervision. It is typically administered as a controlled infusion or bolus, with continuous cardiac and respiratory monitoring throughout the procedure.

Serious risks include life‑threatening arrhythmias, myocardial ischemia, severe hypotension, pulmonary edema, and allergic reactions such as anaphylaxis. Immediate medical attention is required if any of these events occur.

Patients with known hypersensitivity to isoprenaline, uncontrolled hypertension, recent myocardial infarction, severe coronary artery disease, pheochromocytoma, or those taking beta‑blockers without appropriate medical oversight should not receive this medication.